| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
in MCF-10A Human Breast Cells Engenders Dramatic Alterations in Morphology, Proliferation, and Motility1
Department of Chemistry and Biochemistry, Queens College, City University of New York, Flushing, New York 11367
A nonmetastatic human mammary epithelial cell line (MCF-10A) was engineered to overproduce protein kinase C
(PKC
) so as to investigate a role for this isoform in the metastatic phenotype. PKC
transfectants (clone 26
) expressed an 8-fold higher level of PKC
protein without compensatory alterations in other isoforms. Clone 26
proliferated slowly (accumulating in G1 of the cell cycle) but exhibited pronounced increases in motility and adhesion. Elevated expression of cell cycle inhibitor p27 and focal adhesion proteins was observed, whereas E-cadherin expression decreased to undetectable levels. These observations were consistent with the morphology of PKC
transfectants (large, disaggregated, and flat, with lamellipodia and extensive actin fibers) and control cells (small, aggregated, and refractile). Treatment with PKC inhibitors or transfection of a dominant negative (dn) mutant of Rac1, but neither dn RhoA nor dn cdc42, reduced the motility of clone 26
, implicating PKC
catalytic activity and endogenous Rac1, respectively, in the PKC
-induced phenotype. Overall, PKC
overexpression suppresses proliferation while endowing MCF-10A cells with properties consistent with the metastatic phenotype.
This article has been cited by other articles:
![]() |
J. M. Atienza, N. Yu, X. Wang, X. Xu, and Y. Abassi Label-Free and Real-Time Cell-Based Kinase Assay for Screening Selective and Potent Receptor Tyrosine Kinase Inhibitors Using Microelectronic Sensor Array J Biomol Screen, September 1, 2006; 11(6): 634 - 643. [Abstract] [PDF] |
||||
![]() |
W. G. Tharp, R. Yadav, D. Irimia, A. Upadhyaya, A. Samadani, O. Hurtado, S-Y. Liu, S. Munisamy, D. M. Brainard, M. J. Mahon, et al. Neutrophil chemorepulsion in defined interleukin-8 gradients in vitro and in vivo J. Leukoc. Biol., March 1, 2006; 79(3): 539 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chaudhuri, S. M. Colles, P. L. Fox, and L. M. Graham Protein Kinase C{delta}-Dependent Phosphorylation of Syndecan-4 Regulates Cell Migration Circ. Res., September 30, 2005; 97(7): 674 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hara, Y. Saito, T. Hirai, K. Nakamura, K. Nakao, M. Katsuki, and K. Chida Deficiency of Protein Kinase C{alpha} in Mice Results in Impairment of Epidermal Hyperplasia and Enhancement of Tumor Formation in Two-Stage Skin Carcinogenesis Cancer Res., August 15, 2005; 65(16): 7356 - 7362. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhan, D. Yu, J. Liu, J. Hannay, and R. E. Pollock Transcriptional Repression of Protein Kinase C{alpha} via Sp1 by Wild Type p53 Is Involved in Inhibition of Multidrug Resistance 1 P-Glycoprotein Phosphorylation J. Biol. Chem., February 11, 2005; 280(6): 4825 - 4833. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martinez, O. Vogler, J. Casas, F. Barcelo, R. Alemany, J. Prades, T. Nagy, C. Baamonde, P. G. Kasprzyk, S. Teres, et al. Membrane Structure Modulation, Protein Kinase C{alpha} Activation, and Anticancer Activity of Minerval Mol. Pharmacol., February 1, 2005; 67(2): 531 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. T. Makagiansar, S. Williams, K. Dahlin-Huppe, J.-i. Fukushi, T. Mustelin, and W. B. Stallcup Phosphorylation of NG2 Proteoglycan by Protein Kinase C-{alpha} Regulates Polarized Membrane Distribution and Cell Motility J. Biol. Chem., December 31, 2004; 279(53): 55262 - 55270. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsushima, M. Kai, K. Yamada, S.-i. Imai, K. Houkin, H. Kanoh, and F. Sakane Diacylglycerol Kinase {gamma} Serves as an Upstream Suppressor of Rac1 and Lamellipodium Formation J. Biol. Chem., July 2, 2004; 279(27): 28603 - 28613. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cataisson, E. Joseloff, R. Murillas, A. Wang, C. Atwell, S. Torgerson, M. Gerdes, J. Subleski, J.-L. Gao, P. M. Murphy, et al. Activation of Cutaneous Protein Kinase C{alpha} Induces Keratinocyte Apoptosis and Intraepidermal Inflammation by Independent Signaling Pathways J. Immunol., September 1, 2003; 171(5): 2703 - 2713. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yu, I. Morita, K. Shimokado, T. Iwai, and M. Yoshida Amlodipine Modulates THP-1 Cell Adhesion to Vascular Endothelium via Inhibition of Protein Kinase C Signal Transduction Hypertension, September 1, 2003; 42(3): 329 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Kikawa, D. R. Vidale, R. L. Van Etten, and M. S. Kinch Regulation of the EphA2 Kinase by the Low Molecular Weight Tyrosine Phosphatase Induces Transformation J. Biol. Chem., October 11, 2002; 277(42): 39274 - 39279. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zeng, H. Xu, and R. I. Glazer Transformation of Mammary Epithelial Cells by 3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) Is Associated with the Induction of Protein Kinase C{alpha} Cancer Res., June 1, 2002; 62(12): 3538 - 3543. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. da Rocha, D.R.A. Mans, A. Regner, and G. Schwartsmann Targeting Protein Kinase C: New Therapeutic Opportunities Against High-Grade Malignant Gliomas? Oncologist, February 1, 2002; 7(1): 17 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Stapleton, A. Malliri, and B. W. Ozanne Downregulated AP-1 activity is associated with inhibition of Protein-Kinase-C-dependent CD44 and ezrin localisation and upregulation of PKC theta in A431 cells J. Cell Sci., January 7, 2002; 115(13): 2713 - 2724. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Eude, E. Dallot, F. Ferre, and M. Breuiller-Fouche Protein Kinase C{alpha} Is Required for Endothelin-1-Induced Proliferation of Human Myometrial Cells Biol Reprod, January 1, 2002; 66(1): 44 - 49. [Abstract] [Full Text] |
||||
![]() |
N. D. Zantek, J. Walker-Daniels, J. Stewart, R. K. Hansen, D. Robinson, H. Miao, B. Wang, H.-J. Kung, M. J. Bissell, and M. S. Kinch MCF-10A-NeoST: A New Cell System for Studying Cell-ECM and Cell-Cell Interactions in Breast Cancer Clin. Cancer Res., November 1, 2001; 7(11): 3640 - 3648. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Sullivan, M. Stone, J. F. Marshall, F. Uberall, and S. A. Rotenberg Photo-Induced Inactivation of Protein Kinase Calpha by Dequalinium Inhibits Motility of Murine Melanoma Cells Mol. Pharmacol., October 1, 2000; 58(4): 729 - 737. [Abstract] [Full Text] |
||||
![]() |
B. Liu, S. A. Rotenberg, and M. V. Mirkin Scanning electrochemical microscopy of living cells: Different redox activities of nonmetastatic and metastatic human breast cells PNAS, August 29, 2000; 97(18): 9855 - 9860. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Adams, J. D. Clelland, G. D.M. Collett, F. Matsumura, S. Yamashiro, and L. Zhang Cell-Matrix Adhesions Differentially Regulate Fascin Phosphorylation Mol. Biol. Cell, December 1, 1999; 10(12): 4177 - 4190. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |